Skip to main content
FREE SHIPPING THRESHOLD$250 REMAINING
SYSTEM: ACTIVE·INVENTORY // PEPTIDES·ITEM: GLP-1
MK-IV SPECGLP-1
LAT: 34.0522° NLONG: 118.2437° W
RESEARCH ONLYOA-321-GLP1

GLP-1

Endogenous Incretin Hormone

UNIT COST$103.00
STATUSIN STOCK
In stock · Ships in 1-2 business days
QTY
1

MISSION CRITICAL: For in vitro laboratory research only. Not for human or veterinary use. Not evaluated by the FDA. Must be 21+.

SPECIFICATIONS

CAS No.106612-94-6 (GLP-1 7-37)
Mol. Weight3337.73 g/mol
Purity99%+ (HPLC)
FormLyophilized Powder
Storage−20°C · Lyophilized
Mol. FormulaC151H226N40O46

COMPOUND INTEL

REF #OA-321-GLP1
MECHANISM_DUMP

MOLECULAR PROFILE

GLP-1 (glucagon-like peptide-1, 7-37) is the biologically active form of the endogenous incretin hormone glucagon-like peptide-1, derived from proglucagon cleavage. With the molecular formula C₁₅₁H₂₂₆N₄₀O₄₆ and a molecular weight of 3337.73 g/mol (CAS: 106612-94-6), it is a 31-amino-acid peptide studied in pancreatic beta-cell and incretin-pathway models for its interactions with the GLP-1 receptor and downstream Gs-protein coupled cAMP signaling.

AMINO ACID SEQUENCEHis-Ala-Glu-Gly-Thr-Phe-Thr-Ser-Asp-Val-Ser-Ser-Tyr-Leu-Glu-Gly-Gln-Ala-Ala-Lys-Glu-Phe-Ile-Ala-Trp-Leu-Val-Lys-Gly-Arg-Gly
Endogenous Incretin HormoneGLP-1 ReceptorGs-protein coupled signaling

MECHANISM OF ACTION

GLP-1 ReceptorReceptor interaction

Published research demonstrates GLP-1 modulates targeted signaling cascades within cell tissue models.

Gs-protein coupled signalingSignaling cascade

In cellular environments, GLP-1 exhibits selective binding and corresponding pathway activation.

TECHNICAL DATA

CAS No.
106612-94-6 (GLP-1 7-37)
Mol. Formula
C151H226N40O46
Mol. Weight
3337.73 g/mol
Purity
99%+ (HPLC)
Form
Lyophilized Powder
Storage
−20°C · Lyophilized

Scientific Context

Related Research & Analysis

Tirzepatide

Tirzepatide and Dual Receptor Pharmacology: What Two Targets Change

Tirzepatide engages both the GIP and GLP-1 receptors from a single 39-amino-acid sequence, and not evenly. How a GIP-based scaffold reaches a second receptor, why the common "balanced agonist" description does not hold, and what two targets do to attribution. For research purposes only.

Read Full Article
FOR RESEARCH USE ONLY · NOT FOR HUMAN OR VETERINARY USE

Research only

Research updates

Get new-compound announcements and subscriber deals. For research purposes only.